Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69.8M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
26.5M
-
Shares change
-
+3.71M
-
Total reported value, excl. options
-
$1.29B
-
Value change
-
+$190M
-
Number of buys
-
80
-
Number of sells
-
-38
-
Price
-
$48.50
Significant Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q2 2021
135 filings reported holding KYMR - Kymera Therapeutics, Inc. - Common Stock as of Q2 2021.
Kymera Therapeutics, Inc. - Common Stock (KYMR) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.5M shares
of 69.8M outstanding shares and own 38.04% of the company stock.
Largest 10 shareholders include BVF INC/IL (2.63M shares), Redmile Group, LLC (2.53M shares), BlackRock Inc. (2.45M shares), FMR LLC (2.18M shares), VANGUARD GROUP INC (2.04M shares), BAKER BROS. ADVISORS LP (1.96M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.84M shares), STATE STREET CORP (1.34M shares), Deer IX & Co. Ltd. (1.24M shares), and WELLINGTON MANAGEMENT GROUP LLP (828K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.